AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma

Completed · Not applicable

Conditions studied: Asthma

In brief

The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12-15 years, and a caregiver

Key facts

Study ID

NCT04448002

Run by

University of Florida

People needed

320

Starts

2021-04-23

Expected to finish

2026-01-22

Last updated by the study team

2026-04-01

Who can join

Age: 12 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UF Health Pediatrics — Gainesville, Florida, United States
• Nemours Children's Hospital — Jacksonville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.